View in EDS HTML Full Text PDF Full Text

Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination among Adults in the USA Aged 50–59 Years at Increased Risk of Severe RSV Disease.

Saved in:
Bibliographic Details
Title: Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination among Adults in the USA Aged 50–59 Years at Increased Risk of Severe RSV Disease.
Authors: Singer, David1 (AUTHOR) david.a.singer@gsk.com, La, Elizabeth M.1 (AUTHOR), Graham, Jonathan2 (AUTHOR), Molnar, Daniel3 (AUTHOR), Grace, Mei2 (AUTHOR), Poston, Sara1 (AUTHOR), Verelst, Frederik3 (AUTHOR)
Source: Infectious Diseases & Therapy. Dec2025, Vol. 14 Issue 12, p2743-2761. 19p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 189235939
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination among Adults in the USA Aged 50–59 Years at Increased Risk of Severe RSV Disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Singer%2C+David%22">Singer, David</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> david.a.singer@gsk.com</i><br /><searchLink fieldCode="AR" term="%22La%2C+Elizabeth+M%2E%22">La, Elizabeth M.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Graham%2C+Jonathan%22">Graham, Jonathan</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Molnar%2C+Daniel%22">Molnar, Daniel</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Grace%2C+Mei%22">Grace, Mei</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Poston%2C+Sara%22">Poston, Sara</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Verelst%2C+Frederik%22">Verelst, Frederik</searchLink><relatesTo>3</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Infectious+Diseases+%26+Therapy%22">Infectious Diseases & Therapy</searchLink>. Dec2025, Vol. 14 Issue 12, p2743-2761. 19p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189235939
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40121-025-01238-8
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 19
        StartPage: 2743
    Titles:
      – TitleFull: Public Health Impact and Cost-Effectiveness of Adjuvanted RSVPreF3 Vaccination among Adults in the USA Aged 50–59 Years at Increased Risk of Severe RSV Disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Singer, David
      – PersonEntity:
          Name:
            NameFull: La, Elizabeth M.
      – PersonEntity:
          Name:
            NameFull: Graham, Jonathan
      – PersonEntity:
          Name:
            NameFull: Molnar, Daniel
      – PersonEntity:
          Name:
            NameFull: Grace, Mei
      – PersonEntity:
          Name:
            NameFull: Poston, Sara
      – PersonEntity:
          Name:
            NameFull: Verelst, Frederik
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 12
              Text: Dec2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 21938229
          Numbering:
            – Type: volume
              Value: 14
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Infectious Diseases & Therapy
              Type: main
ResultId 1